|
20 Jun 2007 |
Merck Serono and Ambrx to collaborate on development of next generation growth hormone products
|
|
20 Jun 2007 |
Organon's once-a-month contraceptive ring,NuvaRing® completes European authorization
|
|
20 Jun 2007 |
DeveloGen and Teva Enter into Exclusive License Agreement for DeveloGen’s Protein Kinase B Technology for the Treatment of Cancer
|
|
20 Jun 2007 |
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
|
|
20 Jun 2007 |
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
|
|
19 Jun 2007 |
Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
|
|
16 Jun 2007 |
Aurobindo gets USFDA Approval for Trandolapril Tablets
|
|
15 Jun 2007 |
BioSyntech reaches significant BST-CarGel(R) clinical milestone
|
|
15 Jun 2007 |
BioSyntech reaches significant BST-CarGel(R) clinical milestone
|
|
15 Jun 2007 |
Lupin Pharmaceuticals, Inc. Announces Final Approval of Trandolapril Tablets
|
|
14 Jun 2007 |
Lifecell Corporation receives 510(k) clearance for tissue repair product
|
|
14 Jun 2007 |
Lifecell Corporation receives 510(k) clearance for tissue repair product
|
|
14 Jun 2007 |
Watson Receives FDA Final Approval for Generic Wellbutrin XL(R) 300 Mg
|
|
13 Jun 2007 |
IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
|
|
13 Jun 2007 |
Favrille Acquires Anti-CD20 Monoclonal Antibodies from Diversa
|
|
13 Jun 2007 |
Novo Nordisk opens new pilot plant for biopharmaceutical products in Hillerod, Denmark
|
|
13 Jun 2007 |
Penwest Begins Dosing Phase IIa Clinical Study of Nalbuphine ER
|
|
13 Jun 2007 |
Kissei and Eisai sign a license agreement to develop and commercialize Glufast(R), a rapid-acting insulin secretagogue in 10 ASEAN countries
|
|
13 Jun 2007 |
CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
|
|
13 Jun 2007 |
CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
|
|
12 Jun 2007 |
Merck Signs Strategic Alliance With Archemix
|
|
12 Jun 2007 |
Biotec Pharmacon enters Phase III with the diabetic ulcers indication
|
|
12 Jun 2007 |
NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma
|
|
12 Jun 2007 |
Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
|
|
12 Jun 2007 |
Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
|
